Omalizumab Subcutaneous and Prograf (Tacrolimus Granules for Suspension)
Determining the interaction of Omalizumab Subcutaneous and Prograf (Tacrolimus Granules for Suspension) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
Generic Name: tacrolimus
Brand name: Prograf, Astagraf XL, Envarsus XR, Hecoria
Synonyms: Prograf
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Omalizumab Subcutaneous-Prograf (Tacrolimus Injection)
- Omalizumab Subcutaneous-Prograf Intravenous
- Omalizumab Subcutaneous-Prohance
- Omalizumab Subcutaneous-ProHance Injection
- Omalizumab Subcutaneous-Prohist LQ
- Omalizumab Subcutaneous-Prolensa
- Prograf (Tacrolimus Granules for Suspension)-Ombitasvir, Paritaprevir, and Ritonavir
- Prograf (Tacrolimus Granules for Suspension)-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Prograf (Tacrolimus Granules for Suspension)-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Prograf (Tacrolimus Granules for Suspension)-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Prograf (Tacrolimus Granules for Suspension)-Omeclamox-Pak
- Prograf (Tacrolimus Granules for Suspension)-Omega-3 Fatty Acid Capsules